USE OF OUABAIN ANTAGONISTS TO INHIBIT VIRAL INFECTION Read more about USE OF OUABAIN ANTAGONISTS TO INHIBIT VIRAL INFECTION US Application 62/737,899Filed on 2018-09-27
Improved Methods Of Manufacturing Peptide-Based Vaccines Read more about Improved Methods Of Manufacturing Peptide-Based Vaccines US Application 62/674,752Filed on 2018-05-22
A HIGH-YIELD PERFUSION-BASED TRANSIENT GENE EXPRESSION BIOPROCESS Read more about A HIGH-YIELD PERFUSION-BASED TRANSIENT GENE EXPRESSION BIOPROCESS US Application 62/751,204Filed on 2018-10-26
NEW COMPOSITIONS AND DETECTION METHODS FOR ONCHOCERCA VOLVULUS INFECTION Read more about NEW COMPOSITIONS AND DETECTION METHODS FOR ONCHOCERCA VOLVULUS INFECTION US Application 62/682,678Filed on 2018-06-08
Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response Read more about Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response US Application 62/481,432Filed on 2017-04-04
Zika Viral Antigen Constructs Read more about Zika Viral Antigen Constructs US Application 62/568,559Filed on 2017-10-05
Zika Viral Antigen Constructs Read more about Zika Viral Antigen Constructs US Application 62/485,090Filed on 2017-04-13
Zika Viral Antigen Constructs Read more about Zika Viral Antigen Constructs US Application 62/423,398Filed on 2016-11-17
Antibody-mediated Conditioning With Immunosuppression To Enable Allogeneic Transplantation Read more about Antibody-mediated Conditioning With Immunosuppression To Enable Allogeneic Transplantation US Application 62/479,772Filed on 2017-03-31
HIV-1 Multi-Specific Antibodies and Their Use Read more about HIV-1 Multi-Specific Antibodies and Their Use US Application 62/409,097Filed on 2016-10-17